STAT Plus: Sanofi to exit immuno-oncology collaboration with Regeneron
RUBY WALLAU FOR STAT
Sanofi and Regeneron agreed to wind down a partnership, launched in 2015, sooner than is strictly necessary.
Sols 4345-4347: Contact Science is Back on the Table
Hace 20 horas
.jpeg)
No hay comentarios:
Publicar un comentario